Story preview
Halozyme Therapeutics Insider Sold Shares Worth $6,610,501, According to a Recent SEC Filing
About this story
- Published
- Oct 9, 2026, 7:43 AM UTC
Topics in this story
Continue reading on the publisher site for the full article.
Read on publisher →www.marketscreener.com
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee